Use of agonists for persistent organic pollutant (GLP-1) receptor to increase sensitivity to insulin and lipid characteristics

摘要

It refers to the pharmacological components including: (a) 0.001-50mg GLP-1 mimicallic acid containing ch1 deleted or accepted GLP-1; 0.0001-500mg GLP-1 containing ch1 deleted or GLP-1 or 0 receptor nucleic acid; This GLP-1 copolymer contains 0.001-100 UG nucleic acid of vinyl chloride. Its CH-1 has been deleted or GLP-1 receptor per kilogram, or the same concentration of these cells, tissues, organs or animals. The dying person includes at least 10-31 carbamate, SEC ID No.106. This component is useful in the treatment of diseases related to insulin or lipid profile of GLP-1 in cells, tissues, organisms or animals.